Braxia Scientific Corp. reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was CAD 0.488973 million compared to CAD 0.324902 million a year ago. Net loss was CAD 2.17 million compared to CAD 2.52 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the nine months, sales was CAD 1.36 million compared to CAD 1.12 million a year ago. Net loss was CAD 5.48 million compared to CAD 5.32 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.03 a year ago.